四維圖新(002405.SZ):傑發科技獲美國發明專利證書
格隆匯1月14日丨四維圖新(002405.SZ)公佈,近日,公司的全資子公司合肥傑發科技有限公司(以下簡稱“傑發科技”)獲得美國專利商標局頒發的發明專利證書。
該專利(即“一種低壓差分信號發送器以及數據傳輸設備”)的取得是傑發科技堅持持續創新的新成果,其專注於提高車載LVDS顯示接口TX和RX之間的數據傳輸準確率,採用獨特的clock產生方法,有效降低了LVDSclock與data之間的相位差值,提高了TX端的數據採樣準確率,從而提高了傑發科技在車載LVDS接口數據傳輸質量和採樣準確率的技術壁壘。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.